| Product Code: ETC11555581 | Publication Date: Apr 2025 | Updated Date: Sep 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Bhawna Singh | No. of Pages: 65 | No. of Figures: 34 | No. of Tables: 19 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Argentina Central Nervodisorders Therapeutics Market Overview |
3.1 Argentina Country Macro Economic Indicators |
3.2 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume, 2021 & 2031F |
3.3 Argentina Central Nervodisorders Therapeutics Market - Industry Life Cycle |
3.4 Argentina Central Nervodisorders Therapeutics Market - Porter's Five Forces |
3.5 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume Share, By Product Type, 2021 & 2031F |
3.6 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume Share, By Technology Type, 2021 & 2031F |
3.7 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume Share, By End User, 2021 & 2031F |
3.8 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume Share, By Application, 2021 & 2031F |
4 Argentina Central Nervodisorders Therapeutics Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of central nervous system disorders in Argentina |
4.2.2 Growing awareness and focus on mental health in the country |
4.2.3 Advances in medical research leading to the development of new therapies for CNS disorders |
4.3 Market Restraints |
4.3.1 High cost associated with CNS therapeutics |
4.3.2 Limited access to healthcare services in certain regions of Argentina |
4.3.3 Regulatory challenges and approval processes for new therapeutics |
5 Argentina Central Nervodisorders Therapeutics Market Trends |
6 Argentina Central Nervodisorders Therapeutics Market, By Types |
6.1 Argentina Central Nervodisorders Therapeutics Market, By Product Type |
6.1.1 Overview and Analysis |
6.1.2 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume, By Product Type, 2021 - 2031F |
6.1.3 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume, By Neuroprotective Drugs, 2021 - 2031F |
6.1.4 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume, By Gene Therapy, 2021 - 2031F |
6.1.5 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume, By Stem Cell Therapy, 2021 - 2031F |
6.1.6 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume, By Targeted Drug Delivery, 2021 - 2031F |
6.2 Argentina Central Nervodisorders Therapeutics Market, By Technology Type |
6.2.1 Overview and Analysis |
6.2.2 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume, By Small Molecule Therapy, 2021 - 2031F |
6.2.3 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume, By CRISPR Technology, 2021 - 2031F |
6.2.4 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume, By Regenerative Medicine, 2021 - 2031F |
6.2.5 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume, By Nanotechnology, 2021 - 2031F |
6.3 Argentina Central Nervodisorders Therapeutics Market, By End User |
6.3.1 Overview and Analysis |
6.3.2 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume, By Hospitals, 2021 - 2031F |
6.3.3 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume, By Research Institutions, 2021 - 2031F |
6.3.4 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume, By Biotechnology Firms, 2021 - 2031F |
6.3.5 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume, By Pharmaceutical Companies, 2021 - 2031F |
6.4 Argentina Central Nervodisorders Therapeutics Market, By Application |
6.4.1 Overview and Analysis |
6.4.2 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume, By Treatment of Neurodegenerative Disorders, 2021 - 2031F |
6.4.3 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume, By Genetic Disorder Correction, 2021 - 2031F |
6.4.4 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume, By Neuron Regeneration, 2021 - 2031F |
6.4.5 Argentina Central Nervodisorders Therapeutics Market Revenues & Volume, By Precision Medicine, 2021 - 2031F |
7 Argentina Central Nervodisorders Therapeutics Market Import-Export Trade Statistics |
7.1 Argentina Central Nervodisorders Therapeutics Market Export to Major Countries |
7.2 Argentina Central Nervodisorders Therapeutics Market Imports from Major Countries |
8 Argentina Central Nervodisorders Therapeutics Market Key Performance Indicators |
8.1 Patient adherence rates to CNS therapeutics |
8.2 Number of clinical trials conducted for CNS disorders in Argentina |
8.3 Adoption rate of new CNS therapies in the market |
9 Argentina Central Nervodisorders Therapeutics Market - Opportunity Assessment |
9.1 Argentina Central Nervodisorders Therapeutics Market Opportunity Assessment, By Product Type, 2021 & 2031F |
9.2 Argentina Central Nervodisorders Therapeutics Market Opportunity Assessment, By Technology Type, 2021 & 2031F |
9.3 Argentina Central Nervodisorders Therapeutics Market Opportunity Assessment, By End User, 2021 & 2031F |
9.4 Argentina Central Nervodisorders Therapeutics Market Opportunity Assessment, By Application, 2021 & 2031F |
10 Argentina Central Nervodisorders Therapeutics Market - Competitive Landscape |
10.1 Argentina Central Nervodisorders Therapeutics Market Revenue Share, By Companies, 2024 |
10.2 Argentina Central Nervodisorders Therapeutics Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here